109 related articles for article (PubMed ID: 10427121)
1. Expression of keratinocyte growth factor receptor compared with that of epidermal growth factor receptor and erbB-2 in endometrial adenocarcinoma.
Visco V; Carico E; Marchese C; Torrisi MR; Frati L; Vecchione A; Muraro R
Int J Oncol; 1999 Sep; 15(3):431-5. PubMed ID: 10427121
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma.
Siegfried S; Pekonen F; Nyman T; Ammälä M; Rutanen EM
Cancer; 1997 Mar; 79(6):1166-71. PubMed ID: 9070494
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression: is it the same in normal and malignant endometria?
Zarcone R; Bellini P; Cardone G; Vicinanza G; Cardone A
Clin Exp Obstet Gynecol; 1995; 22(4):298-300. PubMed ID: 8777783
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
Reinartz JJ; George E; Lindgren BR; Niehans GA
Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma.
Khalifa MA; Abdoh AA; Mannel RS; Haraway SD; Walker JL; Min KW
Cancer; 1994 Jan; 73(2):370-6. PubMed ID: 8293402
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma.
Niikura H; Sasano H; Matsunaga G; Watanabe K; Ito K; Sato S; Yajima A
Hum Pathol; 1995 Aug; 26(8):892-6. PubMed ID: 7635451
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer.
Srinivasan R; Benton E; McCormick F; Thomas H; Gullick WJ
Clin Cancer Res; 1999 Oct; 5(10):2877-83. PubMed ID: 10537356
[TBL] [Abstract][Full Text] [Related]
10. Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis.
Yamayoshi T; Nagayasu T; Matsumoto K; Abo T; Hishikawa Y; Koji T
J Pathol; 2004 Sep; 204(1):110-8. PubMed ID: 15307144
[TBL] [Abstract][Full Text] [Related]
11. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
12. Expression of the epidermal growth factor system in endometrial cancer.
Adonakis G; Androutsopoulos G; Koumoundourou D; Liava A; Ravazoula P; Kourounis G
Eur J Gynaecol Oncol; 2008; 29(5):450-4. PubMed ID: 19051810
[TBL] [Abstract][Full Text] [Related]
13. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
[TBL] [Abstract][Full Text] [Related]
14. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of keratinocyte growth factor and its receptor in psoriasis.
Finch PW; Murphy F; Cardinale I; Krueger JG
Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium.
Miturski R; Semczuk A; Postawski K; Jakowicki JA
Tumour Biol; 2000; 21(6):358-66. PubMed ID: 11006576
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
[TBL] [Abstract][Full Text] [Related]
20. Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma.
Ferrara F; De Santis L; Mangili F; Sassi I; Luchini S; Mandelli C; Santambrogio G; Cantaboni A
Pathol Res Pract; 1994 Nov; 190(11):1039-43. PubMed ID: 7746737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
